News Focus
News Focus
Followers 84
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: The Other Guy post# 297922

Friday, 05/26/2017 7:32:38 PM

Friday, May 26, 2017 7:32:38 PM

Post# of 347009
Collaborations are all about timing and deal structure ....I suppose you know that hardly anyone knows the financial details pending....and there are many other financial details surrounding Peregrine that may come as a surprise next week.

Two years is about up... All those biomarkers may now come in handy

May 29, 2015
Peregrine, Memorial Sloan Kettering Launch Cancer Collaboration

Peregrine Pharmaceuticals said today it will explore cancer-fighting treatments that combine its phosphatidylserine (PS)-targeting agents—including its lead drug candidate, the Phase III immuno-oncology prospect bavituximab for lung cancer—with other checkpoint inhibitors or immune stimulating agents, through a research collaboration with Memorial Sloan Kettering Cancer Center (MSK).

The value of the collaboration was not disclosed.
...
..
http://www.genengnews.com/gen-news-highlights/peregrine-memorial-sloan-kettering-launch-cancer-collaboration/81251330

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y